Active — Not RecruitingNot Applicable

Development of an Intervention to Enhance Cancer Pain Management

United States150 participantsStarted 2014-04-15

Plain-language summary

This research study is being done to understand how patients with chronic cancer pain take their long-acting opioid medications, and to develop an intervention to enhance cancer pain management.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 21 or older * Currently prescribed a long-acting (LA) opioid for nociceptive cancer pain (extended release oxycodone, extended-release morphine, transdermal fentanyl patches, methadone tablets) * Ability to comprehend study materials in English * Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2 * In charge of administering own pain medications * Part 2 study only: within 4 months of current prescription of LA opioid for nociceptive cancer pain Exclusion Criteria: * Impaired cognition, active substance disorder, or other active, unstable mental health disorder * Current long-acting opioid treatment for pre-existing condition * Part 2 study only: Prior enrollment in the Part 1 study\*\*

What they're measuring

Number of participants who complete study sessions

Timeframe: 2 Years

Number of participants who identify study components as acceptable

Timeframe: 2 years

Trial details

NCT IDNCT03752268

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-11-30

View on ClinicalTrials.gov More Other Cancer trials